KSE - Delayed Quote KRW

Hanmi Pharm. Co., Ltd. (128940.KS)

292,000.00

+3,500.00

+(1.21%)

At close: 3:30:30 PM GMT+9

Hanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico as 'Aditams', Marking the Start of Full-Scale Latin America Expansion

Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED), Gugutams, is entering the Mexican market under the local brand name "Aditams."

PR Newswire last month

128940.KQ

128940.KS
+1.21%
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides in penetrating the Canadian and US markets with innovative products developed by its affiliate, JVM Co., Ltd. (054950.KQ).

PR Newswire 2 months ago

128940.KQ

128940.KS
+1.21%
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical, was recently presented at a major global academic conference, drawing significant attention in the field of immunotherapy.

PR Newswire 5 months ago

128940.KQ

128940.KS
+1.21%
Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss

Hanmi Pharm. Co., Ltd. has announced promising research results for its novel obesity treatment, HM17321. This groundbreaking drug not only augments fat loss but also significantly increases lean muscle mass, marking it as a potential game-changer in obesity management. HM17321 addresses a key limitation in current GLP-1-based therapies, which often lead to muscle loss as a side effect of significant weight reduction.

PR Newswire 6 months ago

128940.KQ

128940.KS
+1.21%

Performance Overview

Return	128940.KS	KOSPI Composite Index (^KS11)
YTD	+4.10%	+9.25%
1-Year	-7.32%	-3.99%
3-Year	+3.43%	+0.66%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Hanmi Pharm. Co., Ltd. (128940.KS)

Hanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico as 'Aditams', Marking the Start of Full-Scale Latin America Expansion

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss

Performance Overview